99 related articles for article (PubMed ID: 22583575)
21. Tumor necrosis factor interaction with gold nanoparticles.
Tsai DH; Elzey S; Delrio FW; Keene AM; Tyner KM; Clogston JD; Maccuspie RI; Guha S; Zachariah MR; Hackley VA
Nanoscale; 2012 May; 4(10):3208-17. PubMed ID: 22481570
[TBL] [Abstract][Full Text] [Related]
22. Self-assembled nanocomplex of PEGylated protamine and heparin-suramin conjugate for accumulation at the tumor site.
Park J; Hwang SR; Choi JU; Alam F; Byun Y
Int J Pharm; 2018 Jan; 535(1-2):38-46. PubMed ID: 29097141
[TBL] [Abstract][Full Text] [Related]
23. PEG-modified protamine with improved pharmacological/pharmaceutical properties as a potential protamine substitute: synthesis and in vitro evaluation.
Chang LC; Lee HF; Chung MJ; Yang VC
Bioconjug Chem; 2005; 16(1):147-55. PubMed ID: 15656586
[TBL] [Abstract][Full Text] [Related]
24. Amplifying the macromolecular crowding effect using nanoparticles.
Zaki A; Dave N; Liu J
J Am Chem Soc; 2012 Jan; 134(1):35-8. PubMed ID: 22175804
[TBL] [Abstract][Full Text] [Related]
25. One-pot aqueous phase growth of biocompatible 15-130 nm gold nanoparticles stabilized with bidentate PEG.
Oh E; Susumu K; Jain V; Kim M; Huston A
J Colloid Interface Sci; 2012 Jun; 376(1):107-11. PubMed ID: 22480398
[TBL] [Abstract][Full Text] [Related]
26. Ultrastable-Stealth Large Gold Nanoparticles with DNA Directed Biological Functionality.
Heo JH; Kim KI; Cho HH; Lee JW; Lee BS; Yoon S; Park KJ; Lee S; Kim J; Whang D; Lee JH
Langmuir; 2015 Dec; 31(51):13773-82. PubMed ID: 26638691
[TBL] [Abstract][Full Text] [Related]
27. Binding enhancement of antigen-functionalized PEGylated gold nanoparticles onto antibody-immobilized surface by increasing the functionalized antigen using alpha-sulfanyl-omega-amino-PEG.
Yoshimoto K; Hoshino Y; Ishii T; Nagasaki Y
Chem Commun (Camb); 2008 Nov; (42):5369-71. PubMed ID: 18985213
[TBL] [Abstract][Full Text] [Related]
28. Quantized folding of plasmid DNA condensed with block catiomer into characteristic rod structures promoting transgene efficacy.
Osada K; Oshima H; Kobayashi D; Doi M; Enoki M; Yamasaki Y; Kataoka K
J Am Chem Soc; 2010 Sep; 132(35):12343-8. PubMed ID: 20712309
[TBL] [Abstract][Full Text] [Related]
29. Cisplatin-tethered gold nanoparticles that exhibit enhanced reproducibility, drug loading, and stability: a step closer to pharmaceutical approval?
Craig GE; Brown SD; Lamprou DA; Graham D; Wheate NJ
Inorg Chem; 2012 Mar; 51(6):3490-7. PubMed ID: 22390791
[TBL] [Abstract][Full Text] [Related]
30. Quantitative investigation of the poly-adenine DNA dissociation from the surface of gold nanoparticles.
Lu W; Wang L; Li J; Zhao Y; Zhou Z; Shi J; Zuo X; Pan D
Sci Rep; 2015 May; 5():10158. PubMed ID: 25974839
[TBL] [Abstract][Full Text] [Related]
31. Completely dispersible PEGylated gold nanoparticles under physiological conditions: modification of gold nanoparticles with precisely controlled PEG-b-polyamine.
Miyamoto D; Oishi M; Kojima K; Yoshimoto K; Nagasaki Y
Langmuir; 2008 May; 24(9):5010-7. PubMed ID: 18386943
[TBL] [Abstract][Full Text] [Related]
32. Cellular uptake and fate of PEGylated gold nanoparticles is dependent on both cell-penetration peptides and particle size.
Oh E; Delehanty JB; Sapsford KE; Susumu K; Goswami R; Blanco-Canosa JB; Dawson PE; Granek J; Shoff M; Zhang Q; Goering PL; Huston A; Medintz IL
ACS Nano; 2011 Aug; 5(8):6434-48. PubMed ID: 21774456
[TBL] [Abstract][Full Text] [Related]
33. Studies on the adsorption property and structure of polyamine-ended poly(ethylene glycol) derivatives on a gold surface by surface plasmon resonance and angle-resolved X-ray photoelectron spectroscopy.
Yoshimoto K; Nozawa M; Matsumoto S; Echigo T; Nemoto S; Hatta T; Nagasaki Y
Langmuir; 2009 Oct; 25(20):12243-9. PubMed ID: 19775137
[TBL] [Abstract][Full Text] [Related]
34. Promoting DNA loading on magnetic nanoparticles using a DNA condensation strategy.
Shan Z; Jiang Y; Guo M; Bennett JC; Li X; Tian H; Oakes K; Zhang X; Zhou Y; Huang Q; Chen H
Colloids Surf B Biointerfaces; 2015 Jan; 125():247-54. PubMed ID: 25454752
[TBL] [Abstract][Full Text] [Related]
35. Dynamic constitutional frameworks for DNA biomimetic recognition.
Catana R; Barboiu M; Moleavin I; Clima L; Rotaru A; Ursu EL; Pinteala M
Chem Commun (Camb); 2015 Feb; 51(11):2021-4. PubMed ID: 25500992
[TBL] [Abstract][Full Text] [Related]
36. Comparison of the nonspecific binding of DNA-conjugated gold nanoparticles between polymeric and monomeric self-assembled monolayers.
Das J; Huh CH; Kwon K; Park S; Jon S; Kim K; Yang H
Langmuir; 2009 Jan; 25(1):235-41. PubMed ID: 19032023
[TBL] [Abstract][Full Text] [Related]
37. Quantification and reactivity of functional groups in the ligand shell of PEGylated gold nanoparticles via a fluorescence-based assay.
Maus L; Spatz JP; Fiammengo R
Langmuir; 2009 Jul; 25(14):7910-7. PubMed ID: 19419188
[TBL] [Abstract][Full Text] [Related]
38. PEG and mPEG-anthracene induce DNA condensation and particle formation.
Froehlich E; Mandeville JS; Arnold D; Kreplak L; Tajmir-Riahi HA
J Phys Chem B; 2011 Aug; 115(32):9873-9. PubMed ID: 21766821
[TBL] [Abstract][Full Text] [Related]
39. Surface modification with alginate-derived polymers for stable, protein-repellent, long-circulating gold nanoparticles.
Kodiyan A; Silva EA; Kim J; Aizenberg M; Mooney DJ
ACS Nano; 2012 Jun; 6(6):4796-805. PubMed ID: 22650310
[TBL] [Abstract][Full Text] [Related]
40. High gene delivery in tumor by intratumoral injection of tetraarginine-PEG lipid-coated protamine/DNA.
Fujita T; Furuhata M; Hattori Y; Kawakami H; Toma K; Maitani Y
J Control Release; 2008 Jul; 129(2):124-7. PubMed ID: 18513820
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
